Biblio
Generation of two patient specific GABRD variants and their isogenic controls for modeling epilepsy. Stem Cell Res. 2024;76:103372.
Generation of eight hiPSCs lines from two pathogenic variants in CACNA1A using the CRISPR-Cas9 gene editing technology. Stem Cell Res. 2023;71:103193.